COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

IMPORTANCE: New York City is a global epicenter for the SARS-CoV-2 outbreak with a significant number of individuals infected by the virus. Patients with multiple myeloma have a compromised immune system, due to both the disease and anti-myeloma therapies, and may therefore be particularly susceptib...

Descripción completa

Detalles Bibliográficos
Autores principales: Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara, Patel, Dhwani, Smith, Eric, Korde, Neha, Lu, Sydney, Mailankody, Sham, Shah, Urvi, Lesokhin, Alexander, Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkacs, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetsky, David, Braunstein, Marc, Gordillo, Christian, Davies, Faith, Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth, Landgren, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302217/
https://www.ncbi.nlm.nih.gov/pubmed/32577667
http://dx.doi.org/10.1101/2020.06.09.20126516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302217/
https://www.ncbi.nlm.nih.gov/pubmed/32577667
http://dx.doi.org/10.1101/2020.06.09.20126516

Ejemplares similares